medline.ch Respirationstrakt Zystische Fibrose

	Roadmap to Global Cystic Fibrosis Care. Pediatr Pulmonol Nasr SZ, Fleifil S, Kamel TB, Nassar MF, Abdel Hamed MH, Fouda NM, Elgendy Y, Fouda E. PMID: 41267340 [PubMed - indexed for MEDLINE]
	Quantitative CT Evaluation of Bronchiectasis Improvement in Cystic Fibrosis after CFTR-Modulator Therapy. Radiol Cardiothorac Imaging Hadj Bouzid AI, Pasche D, Benlala I, Bui S, Macey J, Delmas J, Beaufils F, Denis de Senneville B, Berger P, Dournes G. PMID: 41263663 [PubMed - indexed for MEDLINE]
	Academic-Industrial Collaboration in Synthesis with Real-Time Impact in Medicinal Chemistry: Discovery of Cystic Fibrosis C2 Corrector ABBV-602. ACS Med Chem Lett Voight EA, Gong W, Hardee DJ, Hodges TR, Schrimpf MR, Lathrop SP, Sharland JC, Wei B, Davies HML. PMID: 41256986 [PubMed]
	The Regional Landscape of the Human Colon Culturome in Health and Cystic Fibrosis. bioRxiv Surve SV, Valls RA, Barrack KE, Gwilt LL, Gardner TB, O'Toole GA. PMID: 41256617 [PubMed]
	Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program. Pediatr Pulmonol Kalyoncu MY, Çakar NM, Arslan H, Oksay SC, Selcuk M, Karabulut , Y, Ba, Uzuno, Ta, Ergenekon AP, Girit S, Sakall, Çoku, Çak, Eralp EE, Gokdemir Y, Karakoç F, Karadag B. PMID: 41255258 [PubMed - indexed for MEDLINE]
	A Review of Newborn Screening Programs for Cystic Fibrosis: Are Current Protocols Appropriate for Canada's Diverse Population? Pediatr Pulmonol Cheng SY, Sahin B, Abdulrahem N, Eckford PDW, Zysman-Colman Z, Chilvers M, Stephenson AL, Arpin J, Donnelly C, Doyle K, Fernandez S, Filiaggi C, Liu Z, Nowak A, Smith MJ, Stanojevic S. PMID: 41254982 [PubMed - indexed for MEDLINE]
	The role of salivary biochemical markers and dental indices in the assessment of oral health of Egyptian children with cystic fibrosis: an exploratory study. Sci Rep Salman NR, Elkaragy ES, Al-Shafie TA, Matar MA. PMID: 41254034 [PubMed - indexed for MEDLINE]
	CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial. Nat Commun Knoll RL, Brauny MM, Robert E, Cloos L, Waser L, Hilbert K, Ulmer N, Hillen B, Birkner T, Bartolomaeus TUP, Nitsche O, Jarquín-Díaz VH, Lynch S, Gehring S, Maier L, Poplawska K, Forslund-Startceva SK. PMID: 41253756 [PubMed - indexed for MEDLINE]
	Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev Sousa AS, Rocha-Filho CR, Rocha A, Piva SR, Jahnke N, Trevisani VF, Pinto ACPN. PMID: 41251249 [PubMed - indexed for MEDLINE]
	Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis. J Cosmet Dermatol Smith AD, Lyons CE, Somerville L, Flowers RH, Kaplan E, Albon D. PMID: 41246920 [PubMed - in process]
	Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children. Pediatr Pulmonol Melzer LD, Vigers T, Hanley ET, Messinger A, Hoppe JE, Sagel SD, Zemanick ET. PMID: 41235834 [PubMed - indexed for MEDLINE]
	Adherence to Anti-Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis. Pediatr Pulmonol Holmes M, Palladino M, Joseph Ho HY, Malajczuk CJ, Karpievitch YV, Yeoh D, Edmiston P, Schultz A. PMID: 41235785 [PubMed - indexed for MEDLINE]
	Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study. Int J Mol Sci Volpi S, Ambroni M, Buzzetti R, Cimino G, Gramegna A, Lucanto MC, Ripani P, Ros M, Salvatore D, Spada E, Braggion C, Italian SITTMA Study Group. PMID: 41226552 [PubMed - indexed for MEDLINE]
	Future Perspectives on Targeting the Activated TLR4/NFÎºB Pathway in Cystic Fibrosis: A Possible Interplay Between Ethnopharmacology and microRNA Therapeutics. Molecules Gambari R, Finotti A. PMID: 41226119 [PubMed - indexed for MEDLINE]
	Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis. Eur J Med Chem Lipani A, Mascolo FL, Giuffrida S, Barreca M, Bivacqua R, Spanò V, Raimondi MV, Borrelli A, Venturini A, Guidone D, Genovese M, Montalbano A, Galietta LJV, Barraja P. PMID: 41223568 [PubMed - as supplied by publisher]
	Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use. Pediatr Pulmonol Swanston V, Bone JN, Richmond M, Goldfarb D, Rayment JH. PMID: 41221812 [PubMed - indexed for MEDLINE]
	Eliciting required and desired diagnostic test characteristics to develop patient-focused target product profiles (TPPs) for diagnosing infection and exacerbations in cystic fibrosis. NIHR Open Res Howe N, Takawira C, Naseem R, Green K. PMID: 41220810 [PubMed]
	Experience of parenting children and adolescents with cystic fibrosis: A systematic review of qualitative studies and meta-synthesis. Respir Med Xavier D, Silva W, Correa F, Porto I, Soares L, Melgaço G, Oliveira V, Lima V, Oliveira M. PMID: 41213341 [PubMed - indexed for MEDLINE]
	Yoga for psychological outcomes and quality of life in non-cystic fibrosis bronchiectasis: a controlled study. Front Psychiatry Hei L, Zhang Y, Si Y, Bai L. PMID: 41210136 [PubMed]
	Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis-Maternal Health Service: A Retrospective Study. BJOG Scott R, Downes A, Weitnauer L, Dobra R, Singh N, Robinson R, Diable E, Collins S, Bowman E, Tobin T, Jones A, Simmonds N, Felton I. PMID: 41208508 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 19527

Seite 1 von 977



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung